Publications by authors named "Michael Witten"

Claim this Profile
D
Discovery of INCB126503 as a Potent and Selective FGFR2/3 Inhibitor.
Minh H Nguyen, Anlai Wang, Lisa Truong, Ke Zhang, Hai-Fen Ye, Michael R Witten

ACS Med Chem Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive-behavioral therapy and exercise training in adolescent females with elevated depression symptoms and at-risk for type 2 diabetes: Protocol for a randomized controlled trial.
Ana M Gutierrez-Colina, Madison Bristol, Emma L M Clark, Natalia Sanchez, Lauren D Gulley, Michael Witten

Contemp Clin Trials· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach.
Minh H Nguyen, Hai-Fen Ye, Yao Xu, Lisa Truong, April Horsey, Michael R Witten

ACS Med Chem Lett· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Selective Inhibitors of Wild-Type and Gatekeeper Mutant Fibroblast Growth Factor Receptor (FGFR) 2/3.
Artem Shvartsbart, Jeremy J Roach, Michael R Witten, Holly Koblish, Jennifer J Harris

J Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2.
Minh H Nguyen, Onur Atasoylu, Liangxing Wu, Kanishk Kapilashrami, Michelle Pusey, Michael R Witten

ACS Med Chem Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ALK2 with bicyclic pyridyllactams.
Michael R Witten, Liangxing Wu, Cheng-Tsung Lai, Kanishk Kapilashrami, Michelle Pusey

Bioorg Med Chem Lett· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhodium(III)-Catalyzed Imidoyl C-H Activation for Annulations to Azolopyrimidines.
Kim Søholm Halskov, Michael R Witten, Gia L Hoang, Brandon Q Mercado, Jonathan A Ellman

Org Lett· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.
Michael R Witten, Lisa Wissler, Melanie Snow, Stefan Geschwindner, Jon A Read

J Med Chem· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Simple Primary Amine Catalyst for Enantioselective α-Hydroxylations and α-Fluorinations of Branched Aldehydes.
Michael R Witten, Eric N Jacobsen

Org Lett· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic asymmetric synthesis of 8-oxabicyclooctanes by intermolecular [5+2] pyrylium cycloadditions.
Michael R Witten, Eric N Jacobsen

Angew Chem Int Ed Engl· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual catalysis in enantioselective oxidopyrylium-based [5 + 2] cycloadditions.
Noah Z Burns, Michael R Witten, Eric N Jacobsen

J Am Chem Soc· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute calcium ingestion attenuates exercise-induced disruption of calcium homeostasis.
Daniel W Barry, Kent C Hansen, Rachael E van Pelt, Michael Witten, Pamela Wolfe

Med Sci Sports Exerc· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid phase synthesis of hydrogen bond surrogate derived alpha-helices: resolving the case of a difficult amide coupling.
Anupam Patgiri, Michael R Witten, Paramjit S Arora

Org Biomol Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does nutritional supplementation influence adaptability of muscle to resistance training in men aged 48 to 72 years.
Jack M Carter, Debra A Bemben, Allen W Knehans, Michael G Bemben, Michael S Witten

J Geriatr Phys Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis